Our results are consistent with the hypothesis that human circulating DLK1 is, at least partially, of (fetally derived) placental origin in pregnancy and may have a role in stimulating both maternal insulin resistance and compensatory hyperinsulinemia, which in turn might increase fetal weight gain due to the increased availability of nonglucose nutrients. The gene discussed is DLK1; the disease is hyperinsulinism.